2002
DOI: 10.3892/ijo.20.2.319
|View full text |Cite
|
Sign up to set email alerts
|

A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 0 publications
1
14
0
Order By: Relevance
“…The RGD sequence is present in many ECM proteins and intracellular proteins, including FN, LN, osteopontin, and various collagens [23,24]. Synthetic RGD-containing peptides may bind several integrins, especially ␣ 3 ␤ 1 and ␣ 5 ␤ 1 , and they competitively occupy integrin receptor-binding sites, thus suppressing communication between tumor cells and BM proteins, with a resulting effect on adhesion, migration, and tumor metastasis [25][26][27]. Despite these observations, the definite roles of BM proteins in the invasive process of malignant tumors are still not clear, and studies on the interaction of BM proteins and integrins have been rare.…”
Section: Introductionmentioning
confidence: 99%
“…The RGD sequence is present in many ECM proteins and intracellular proteins, including FN, LN, osteopontin, and various collagens [23,24]. Synthetic RGD-containing peptides may bind several integrins, especially ␣ 3 ␤ 1 and ␣ 5 ␤ 1 , and they competitively occupy integrin receptor-binding sites, thus suppressing communication between tumor cells and BM proteins, with a resulting effect on adhesion, migration, and tumor metastasis [25][26][27]. Despite these observations, the definite roles of BM proteins in the invasive process of malignant tumors are still not clear, and studies on the interaction of BM proteins and integrins have been rare.…”
Section: Introductionmentioning
confidence: 99%
“…The peptide purity was monitored on a RP-HPLC column Atlantis TM dC 18 , 4.6×150 mm, particle size 5μm, mobile phase: acetonitrile/deionised water 40/60 (v/v), at 25°C, flow rate: 1ml/min, and UV detection -206 nm. The correct molecular masses were confirmed by ESI-MS. For R(NO 2 )GD, GF -C 12 …”
Section: Synthesismentioning
confidence: 99%
“…Examples of such radio-imaging agents include [99mTc]apticide, which can be used in imaging deep vein thrombosis [10]. Several modifications of RGD peptides, including polymerisation, coupling with carriers and substitution by peptidomimetics, were performed to enhance the anti-tumour properties and lengthen the degradation time in vivo [11][12][13][14]. RGD peptides conjugated with different cytostatic agents are likely to exhibit an antitumour and antiangiogenic synergetic effect.…”
Section: Introductionmentioning
confidence: 99%
“…We also found that GRGDS, in vitro, can bind to b1 integrins and switch on the downstream signal transduction, consequently enhancing the mobility and MMP secretion of HCC cells, so the effects of GRGDS on invasion and metastasis are ambivalent. Recent reports showed that some chemical modification of the original RGD peptide can achieve the property of inhibiting the degradation of the extracellular matrix by MMP-2 and MMP-9 in vitro (Fujii et al 1998;Tsuchiya et al 2002).…”
Section: Discussionmentioning
confidence: 98%
“…The RGD sequence is present in many extracellular matrix proteins and intracellular proteins, including FN, LN, osteopontin, and various collagens (Cachau et al 1989). Synthetic RGD-containing peptides may bind several integrins, especially a3b1 (VLA-3) and a5b1 (VLA-5), and competitively occupy the binding sites of the integrin receptors, thus suppress the communication of tumor cells with BM proteins, and affect adhesion, migration, and tumor metastasis (Zitzmann et al 2002;Tsuchiya et al 2002;Okroj et al 2003).…”
Section: Introductionmentioning
confidence: 98%